Literature DB >> 1529527

Inhibition of replication of HIV-1 by retroviral vectors expressing tat-antisense and anti-tat ribozyme RNA.

K M Lo1, M A Biasolo, G Dehni, G Palú, W A Haseltine.   

Abstract

A ribozyme was constructed that specifically cleaves RNA that contains the first coding exon of the tat gene of HIV-1. This anti-tat ribozyme was incorporated into a Moloney murine leukemia virus vector. A sequence containing only the 48-nucleotide antisense region of the ribozyme was also inserted into the retroviral vector. Human T-cell lines constitutively producing the tat-antisense and the anti-tat ribozyme RNA were created by transduction into Jurkat cells. When challenged with HIV-1, both the tat-antisense and anti-tat ribozyme-producing cells inhibited the replication of HIV-1. The antisense vector conferred a greater resistance to HIV-1 replication than did the anti-tat ribozyme vector.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1529527     DOI: 10.1016/0042-6822(92)91203-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  32 in total

1.  RNA double cleavage by a hairpin-derived twin ribozyme.

Authors:  C Schmidt; R Welz; S Müller
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

2.  Inhibition of hepatitis B virus X gene expression by novel DNA enzymes.

Authors:  R Goila; A C Banerjea
Journal:  Biochem J       Date:  2001-02-01       Impact factor: 3.857

Review 3.  Inhibition of gene expression in human cells using RNase P-derived ribozymes and external guide sequences.

Authors:  Kihoon Kim; Fenyong Liu
Journal:  Biochim Biophys Acta       Date:  2007-09-29

Review 4.  Antiviral therapy for human immunodeficiency virus infections.

Authors:  E De Clercq
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

Review 5.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

Review 6.  Antisense and ribozyme constructs in transgenic animals.

Authors:  D L Sokol; J D Murray
Journal:  Transgenic Res       Date:  1996-11       Impact factor: 2.788

7.  Regulation of CAT protein by ribozyme and antisense mRNA in transgenic mice.

Authors:  D L Sokol; R J Passey; A G MacKinlay; J D Murray
Journal:  Transgenic Res       Date:  1998-01       Impact factor: 2.788

Review 8.  Antiviral ribozymes. New jobs for ancient molecules.

Authors:  A Menke; G Hobom
Journal:  Mol Biotechnol       Date:  1997-08       Impact factor: 2.695

9.  Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.

Authors:  L Q Sun; L Wang; W L Gerlach; G Symonds
Journal:  Nucleic Acids Res       Date:  1995-08-11       Impact factor: 16.971

10.  A new antisense tRNA construct for the genetic treatment of human immunodeficiency virus type 1 infection.

Authors:  M A Biasolo; A Radaelli; L Del Pup; E Franchin; C De Giuli-Morghen; G Palu
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.